Endocrine Society Names Kate Fryer as Chief Executive Officer

Fryer headshot

The Endocrine Society is excited to announce the selection of Kate Fryer as the organization’s next chief executive officer. Fryer has served in numerous scientific association leadership positions with deep experience in strategic planning, membership, scientific publishing, communications, society operations, as well as meetings and conferences.

“The year of COVID-19 was difficult for everyone, but our Society successfully pivoted when necessary, identified new solutions, and emerged stronger than it’s ever been,” says Endocrine Society President Gary D. Hammer, MD, PhD, of the University of Michigan in Ann Arbor. “Kate brings the perfect blend of leadership and association experience to not only build upon our momentum, but to propel us even further forward.”

Fryer comes to the Endocrine Society from the American Chemical Society (ACS) where she served as executive vice president, Membership & Society Services. Her focus was on modernizing their membership model and expanding and virtualizing their meetings and exposition portfolio. Prior to her position at ACS, Fryer was the deputy executive director at the Society for Neuroscience where she led the launch of their open-access journal as well as their online learning platform.

“It is an honor to serve as CEO for an organization so well-regarded for its long history of dedicated members and talented staff,” Fryer says. “This role will pair my passion for advancing and funding foundational research and the basic-to-translational-to-clinical continuum that the Endocrine Society so holistically embodies.”

“As Kate comes on board, it’s important to recognize the contributions of the interim CEO, Dr. Robert Lash,” says Society president-elect Carol Wysham, MD, clinical professor of medicine at the University of Washington. “Facing one of our most difficult years, Rob and the staff displayed remarkable nimbleness so that the pandemic would not hinder our mission to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide.”

Fryer will officially begin her role as chief executive officer on April 6.

PHOTO: Joe Shymanski at Joe Shymanski Photography

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in